Nytol helps UK beat its sleep struggles
This article was originally published in OTC Bulletin & The Rose Sheet
Perrigo is aiming to address the fears people have around sleep aids with a series of “empathetic” television commercials for its Nytol brand in the UK.
You may also be interested in...
Perrigo has launched a UK pharmacy-facing trade campaign for Nytol to help pharmacists and pharmacy-staff get over their misconceptions about sleep aids and have better conversations with consumers about their sleep problems.
AstraZeneca and Novavax have not filed EUAs for their vaccines, and they never might. The pathway remains viable in the short-term, but as BLAs are approved and supplies are no longer short, the window may close.
Emergency use authorization in 12-15 year-olds follows announcement of a June advisory committee meeting on pediatric data requirements, including the FDA’s criteria for younger children. Authorization for US adolescents has raised ethical questions about prioritizing this lower-risk group over hard-hit populations overseas.